This federal Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), provides $526,902 to the University of California, Los Angeles (UCLA) to deliver novel statistical methods, computational algorithms, and user-friendly software to study individual health trajectories relevant to disease onset and progression for biobank-scale real-world data. The project aims to push forward several frontiers in biostatistics, optimization, and clinical medicine, particularly in areas like personalized diabetes management, dynamic prediction, and early detection of disease progression. The project will leverage UCLA's expertise, facilities, and partnerships to support this transformative precision medicine research over the award period from March 2025 to February 2029.
Generated 3/25/25, 4:54 AM